Abstract Library

#3695 Pancreatic steatosis and its correlation with clinicopathological feature in patients with pancreatic neuroendocrine neoplasms

Introduction: The incidence of pancreatic neuroendocrine neoplasms (pNENs) has been increasing year by year, and pancreatic steatosis has been paid more and more attention by clinicians.

Conference:

Presenting Author:

Authors: Li Y, Yang J, Fan Z, Liu S, Meng Y,

Keywords: pancreatic steatosis, fatty liver, pancreatic neuroendocrine neoplasm, blood lipid, prognosis,

#3595 Effects of curcumin on proliferation of pancreatic neuroendocrine tumor cells

Introduction: Medical studies have shown that curcumin has the effects of lowering blood lipids, anti-tumor, anti-inflammatory, choleretic and antioxidant. In recent years, domestic and foreign studies have reported that curcumin has an increasingly prominent effect on inhibiting the proliferation of tumor cells, but the effect of curcumin on pancreatic neuroendocrine tumor cells has not been studied.

Conference:

Presenting Author: Han D

Authors: Han D, Du H,

Keywords: Curcumin, Pancreatic Neuroendocrine Tumor, Cells, Inhibitors,

#320 Predictors of Clinical Response to Everolimus in Patients with Well-differentiated Metastatic Pancreatic NETs

Introduction: Everolimus (E) is an mTOR inhibitor with promising antitumor activity in patients with NETs. Predictor factors of response could improve the clinical use of this compound.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: De Martino M, Ducreux M, Dromain C, Duvillard P, Guigay J, Leboulleux S,

Keywords: everolimus, mTOR, RECIST, pancreas, neuroendocrine, tumor, proliferative index, predictor,